Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Humane Stocks to Buy Now

In this article, we will be taking a look at the 10 best Humane stocks to buy now. To see more such stocks click 5 Best Humane Stocks to Buy Now.

There isn’t a clear definition of the concept of humane business, primarily because it is an emerging theme in corporate culture. However, the concept can be understood as a way of doing business that cares for humanity (i.e., respects human freedom, well-being, and dignity) and has concern for the Earth (i.e., focuses on environmental conservation).

In a prior piece, we delved deeply into ESG investing and its potential to enable investors to make a positive impact on the world. However, there is another angle of human business activity that one can argue is a subset of ESG — it involves companies that do not test on animals.

The inhumane practice of animal testing for diverse reasons is widespread in the global corporate culture. We noted that cosmetics and medical research companies are the worst offenders. In fact, People for the Ethical Treatment of Animals (PETA), a nonprofit, tax-exempt 501(c)(3) corporation, lists more than 200 companies that do tests on animals. Interestingly, an overwhelming majority are beauty and fashion and pharmaceutical companies.

According to a PwC report, ESG investing – investing activity that focuses on environmental, social and governance factors – is growing exponentially in global markets. The report estimates that ESG investing will reach $33.9 trillion by 2026. In other words, 21.5% of total assets under management in 2026 will be invested in ESG-focused businesses.

ESG investing involves seeking out humane companies that do not conduct animal testing. Thankfully, PETA also lists the companies that do not test on animals, making it easy for investors to make the right choice. In addition, many other publicly traded corporations are strong defenders of animal rights, making them humane by association. For example, Microsoft Corporation (NASDAQ:MSFT) is not only on the PETA ‘safe list’ but is also actively involved in animal welfare advocacy. Accenture Plc (NYSE:ACN) is another major corporation that does well regarding ESG. In this regard, this article intends to provide investors with a list of 10 best humane stocks to buy now.

Our Methodology

For this article we focused more on companies that avoid any tests on animals, are working to reduce carbon footprint and have ethical practices and standards. Our research started with a thorough analysis of the PETA ‘safe list’ – these are the companies that have been ascertained to not be involved in any form of animal cruelty. To ensure the list provides a more accurate representation of humane stocks in the US, we expanded our research to The Food Service Industry Protein Sustainability Scorecard, an index maintained by The Humane Society of the United States. We also read social media posts and forum discussions extensively to ensure we select the best humane companies. From the long list of companies we got after our research, we narrowed down to 10 companies with the highest number of hedge fund investors.

Best Humane Stocks to Buy Now

10. Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH)

Market Capitalization as of April 13: $48.76 million

Number of Hedge Fund Holders: 1

Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) provides aesthetic medical services, including surgical and non-surgical treatments and general healthcare services in China, Hong Kong, and Singapore. It operates 15 treatment centers and plans to maintain and strengthen its market position and brand in China’s aesthetic medical treatment market while expanding its Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) presence globally.

Amidst the COVID-19 pandemic in 2020, Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) ensured the safe provision of aesthetic medical services, giving utmost priority to high standards, a robust medical team, and top-notch services for customer satisfaction. The company is actively developing aesthetic medical services with a focus on R&D of technology, expanding its customer base, and aiming to achieve the goal of “safety and beauty.” They plan to use their plastic surgery experience and grasp industry opportunities to upgrade products and services with customer-centricity and technology. Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH) is optimistic about overcoming uncertainties and providing stakeholder value.

At the end of the fourth quarter of 2022, 1 hedge fund in the database of Insider Monkey held stakes worth $17,000 in Aesthetic Medical International Holdings Group Limited (NASDAQ:AIH), down from 2 in the preceding quarter worth $45,000.

9. IRIDEX Corporation (NASDAQ:IRIX)

Market Capitalization as of April 13: $35.58 million

Number of Hedge Fund Holders: 2

IRIDEX Corporation (NASDAQ:IRIX) is a medical device company specializing in developing and commercializing laser-based medical systems for treating eye diseases. The company has taken steps to reduce its environmental impact, such as implementing a waste management program to minimize waste generation. IRIDEX Corporation (NASDAQ:IRIX) also strives to reduce energy consumption by using energy-efficient equipment and implementing energy conservation measures.

In terms of animal welfare, IRIDEX Corporation (NASDAQ:IRIX) does not conduct animal testing on any of its products and is committed to finding alternative methods of testing that do not involve animals. The company is also committed to ensuring the safety and well-being of its employees and customers by adhering to rigorous safety standards and providing training and support to ensure the safe use of its products.

IRIDEX Corporation (NASDAQ:IRIX) has an overall rating of ‘Moderate Buy,’ derived from 1 buy rating and 1 hold rating, and no sell ratings. The average price target for IRIDEX Corporation (NASDAQ:IRIX) has been set by analysts at $4.63.

According to Insider Monkey data, 2 hedge funds owned $884,000 stakes in IRIDEX Corporation (NASDAQ:IRIX) in the fourth quarter of 2022. This is up from 1 hedge fund in the preceding quarter with stakes worth $1.09 million in the company.

Like Microsoft Corporation (NASDAQ:MSFT), and Accenture Plc (NYSE:ACN), IRIDEX Corporation (NASDAQ:IRIX) is one of the best Humane stocks to buy now.

8. Alpha Pro Tech, Ltd. (NYSE:APT)

Market Capitalization as of April 13: $50.77 million

Number of Hedge Fund Holders: 3

Alpha Pro Tech, Ltd. (NYSE:APT)’s main business is producing protective apparel garments, face masks, and face shields for individuals, products, and environments. They also offer construction weatherization building products for housing markets. Alpha Pro Tech, Ltd. (NYSE:APT) produces and sells its products under its own “Alpha Pro Tech” brand name and private labels. Alpha Pro Tech has two business segments: Building Supply which includes construction weatherization products and other woven materials, and Disposable Protective Apparel, which includes head-to-toe protective garments, face masks, and face shields.

Alpha Pro Tech, Ltd. (NYSE:APT)’s shares have gained over 4.86% in the past month.

As of the fourth quarter of 2022, 3 hedge funds in Insider Monkey’s database held stakes in Alpha Pro Tech, Ltd. (NYSE:APT). The most prominent shareholder in Alpha Pro Tech, Ltd. (NYSE:APT) is Ken Griffin’s, Citadel Investment Group, with 45,733 shares valued at $183,847.

7. Great Elm Group Inc. (NASDAQ:GEG)

Market Capitalization as of April 13: $66.03 million

Number of Hedge Fund Holders: 8

Great Elm Group Inc. (NASDAQ:GEG) is a publicly-traded company that operates in the durable medical equipment and investment management sectors. The company provides respiratory care equipment and supplies, sleep study services, and medical equipment rentals. In addition, Great Elm Group Inc. (NASDAQ:GEG) manages a portfolio of long-duration and permanent capital vehicles across various alternative strategies, including credit, real estate, and specialty finance.

Great Elm Group Inc. (NASDAQ:GEG) commits to social responsibility and ethical business practices, as stated on its website. Great Elm Group aims to operate with integrity, respect, and social responsibility and to have a positive and sustainable impact on society. While the financial services industry may not directly impact the environment or animals, Great Elm Group Inc. (NASDAQ:GEG) likely complies with relevant laws and regulations related to environmental and animal protection as a responsible corporate citizen.

At the end of the fourth quarter of 2022, 8 hedge funds in the database of Insider Monkey held stakes worth $19.27 million in Great Elm Group Inc. (NASDAQ:GEG), the same as in the previous quarter, worth $20.01 million. Among these hedge funds, Becker Drapkin Management is the company’s most notable stakeholder, with 3.55 million shares worth $7.17 million.

6. Inogen Inc. (NASDAQ:INGN)

Market Capitalization as of April 13: $301.36 million

Number of Hedge Fund Holders: 13

Inogen Inc. (NASDAQ:INGN) is a medical technology company that develops and manufactures portable oxygen concentrators for patients with chronic respiratory conditions. Inogen Inc. (NASDAQ:INGN) adheres to industry standards and ethical practices, conducting business ethically and complying with laws and regulations. In addition, they follow environmental regulations and standards, reducing waste and conserving energy and water to reduce their environmental impact. In terms of animal welfare, Inogen Inc. (NASDAQ:INGN) does not conduct animal testing and requires their suppliers to meet ethical testing standards.

In January, Inogen Inc. (NASDAQ:INGN) achieved regulatory milestones in the EU and the US to support its portable oxygen concentrator products. The company received European Medical Device Regulation certification in December 2022, allowing them to sell and commercialize Inogen One G4 and Inogen One G5 portable oxygen concentrators in the EU. In addition, Inogen Inc. (NASDAQ:INGN) received FDA clearance for a new portable oxygen concentrator, Rove 4, in December, which will launch in the US in the second half of 2023.

The consensus rating for Inogen Inc. (NASDAQ:INGN) is ‘Moderate Buy,’ with 1 buy rating and 2 hold ratings. The highest analyst price target is $26, while the lowest forecast is $21. Along with Microsoft Corporation (NASDAQ:MSFT) and Accenture Plc (NYSE:ACN), Inogen Inc. (NASDAQ:INGN) is one of the best humane stocks to buy now.

According to Insider Monkey data, Inogen Inc. (NASDAQ:INGN) had 13 hedge funds as of the end of the fourth quarter of 2022. Ali Motamed’s Invenomic Capital Management is the company’s notable stakeholder in Q4 2022, with 380,254 shares worth $7.49 million.

In its Q2 2022 investor letter, Baron Funds specifically mentioned Inogen, Inc. (NASDAQ:INGN):

“Inogen, Inc. (NASDAQ:INGN), a medical device company that manufactures portable oxygen concentrators for patients with breathing issues, is a market leader, but like Advanced Energy, is constrained by chip supply, so it is dramatically under-earning versus the demand it is seeing for its products. We believe Inogen is trading at only 16 times next year’s adjusted cash flow (at lower-than-normal margins), and it is trading at only 2 times our out year cash flow estimates. Again, this is a potential multi-bagger investment over our longer-term investment horizon.

Another reason we are excited about the portfolio going forward is that we have been taking advantage of the current market dislocation to upgrade the quality of the portfolio. During the past two quarters, we have been able to purchase quality companies that were previously out of our reach due to market capitalization limitations. Because the whole market sold off to such a great extent, there were some high-quality “babies” that got thrown out with the “bathwater.”

Click to continue reading and see 5 Best Humane Stocks to Buy Now.

Suggested articles:

Disclosure: None. 10 Best Humane Stocks to Buy Now is originally published on Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

A New Dawn is Coming to U.S. Stocks

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…